Exploring novel circulating biomarkers in hormone-producing endocrine tumors

Takamura Toshinari0 个研究点目标入组 420 人开始时间: 2020年10月8日最近更新: 2023年10月17日

试验速览

暂无简介。

•Selection criteria
•1) From April 1, 2002 to December 31, 2023, a hormone-producing endocrine tumor that was diagnosed by functional tests and imaging tests at our hospital, endocrinology / metabolism internal medicine, former first internal medicine, and former second internal medicine. In addition, patients with abnormal metabolism (obesity, hypertension, abnormal glucose metabolism, cardiovascular disease, non-alcoholic fatty liver disease) who are not diagnosed as hormone production, and patients with non-hormone-producing endocrine tumors. Each diagnostic criterion follows each guideline and consensus statement.
•2) Being over 20 years old and able to go to the hospital.
•3) The functions of major organs (below) are retained by clinical examination within 30 days before registration.
•1 White blood cell : 3,000 <= WBC <15,000 / mcL
•2 Hemoglobin: Hb >= 10.0 g / dL
•3 Platelet count: Platelet >= 50,000 / mcL
•4 Total bilirubin: T.Bil <= 2.0 mg / dL
•5 Serum creatinine: Cr <= 2.5 mg / dL
•4) Patients who have received sufficient explanation before participating in this study, and who have obtained sufficient understanding and voluntary written consent of the patient.

•Exclusion criteria
•1) using oral or intravenous steroids.
•2) serious infection, before or after surgery, or if you have serious trauma.
•3) malignant tumor (including a history).
•4) the principal investigator or the investigator judges that it is inappropriate as the subject of this research.

发起方

Takamura Toshinari